Your browser doesn't support javascript.
loading
Structure-based design of a single-chain triple-disulfide-stabilized fusion-glycoprotein trimer that elicits high-titer neutralizing responses against human metapneumovirus.
Ou, Li; Chen, Steven J; Teng, I-Ting; Yang, Lijuan; Zhang, Baoshan; Zhou, Tongqing; Biju, Andrea; Cheng, Cheng; Kong, Wing-Pui; Morano, Nicholas C; Stancofski, Erik-Stephane D; Todd, John-Paul; Tsybovsky, Yaroslav; Wang, Shuishu; Zheng, Cheng-Yan; Mascola, John R; Shapiro, Lawrence; Woodward, Ruth A; Buchholz, Ursula J; Kwong, Peter D.
Afiliación
  • Ou L; Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Chen SJ; Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Teng IT; Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Yang L; Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, Maryland, United States of America.
  • Zhang B; Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Zhou T; Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Biju A; Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Cheng C; Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Kong WP; Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Morano NC; Zuckerman Mind Brain Behavior Institute, Columbia University, New York, New York, United States of America.
  • Stancofski ED; Department of Biochemistry and Molecular Biophysics, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, United States of America.
  • Todd JP; Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Tsybovsky Y; Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Wang S; Electron Microscopy Laboratory, Cancer Research Technology Program, Frederick National Laboratory for Cancer Research, Frederick, Maryland, United States of America.
  • Zheng CY; Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Mascola JR; Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Shapiro L; Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, United States of America.
  • Woodward RA; Zuckerman Mind Brain Behavior Institute, Columbia University, New York, New York, United States of America.
  • Buchholz UJ; Department of Biochemistry and Molecular Biophysics, Columbia University Vagelos College of Physicians and Surgeons, New York, New York, United States of America.
  • Kwong PD; Vaccine Research Center, National Institutes of Health, Bethesda, Maryland, United States of America.
PLoS Pathog ; 19(9): e1011584, 2023 09.
Article en En | MEDLINE | ID: mdl-37738240
ABSTRACT
The Pneumoviridae family of viruses includes human metapneumovirus (HMPV) and respiratory syncytial virus (RSV). The closely related Paramyxoviridae family includes parainfluenza viruses (PIVs). These three viral pathogens cause acute respiratory tract infections with substantial disease burden in the young, the elderly, and the immune-compromised. While promising subunit vaccines are being developed with prefusion-stabilized forms of the fusion glycoproteins (Fs) of RSV and PIVs, for which neutralizing titers elicited by the prefusion (pre-F) conformation of F are much higher than for the postfusion (post-F) conformation, with HMPV, pre-F and post-F immunogens described thus far elicit similar neutralizing responses, and it has been unclear which conformation, pre-F or post-F, would be the most effective HMPV F-vaccine immunogen. Here, we investigate the impact of further stabilizing HMPV F in the pre-F state. We replaced the furin-cleavage site with a flexible linker, creating a single chain F that yielded increased amounts of pre-F stabilized trimers, enabling the generation and assessment of F trimers stabilized by multiple disulfide bonds. Introduced prolines could increase both expression yields and antigenic recognition by the pre-F specific antibody, MPE8. The cryo-EM structure of a triple disulfide-stabilized pre-F trimer with the variable region of antibody MPE8 at 3.25-Å resolution confirmed the formation of designed disulfides and provided structural details on the MPE8 interface. Immunogenicity assessments in naïve mice showed the triple disulfide-stabilized pre-F trimer could elicit high titer neutralization, >10-fold higher than elicited by post-F. Immunogenicity assessments in pre-exposed rhesus macaques showed the triple disulfide-stabilized pre-F could recall high neutralizing titers after a single immunization, with little discrimination in the recall response between pre-F and post-F immunogens. However, the triple disulfide-stabilized pre-F adsorbed HMPV-directed responses from commercially available pooled human immunoglobulin more fully than post-F. Collectively, these results suggest single-chain triple disulfide-stabilized pre-F trimers to be promising HMPV-vaccine antigens.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Virus Sincitial Respiratorio Humano / Metapneumovirus Límite: Aged / Animals / Humans Idioma: En Revista: PLoS Pathog Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Virus Sincitial Respiratorio Humano / Metapneumovirus Límite: Aged / Animals / Humans Idioma: En Revista: PLoS Pathog Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos